Nuvectis Pharma annual total assets
2021
2022
2023
2024
2025
Nuvectis Pharma Total Assets Growth & History (NVCT)
Nuvectis Pharma's total assets was $31.7M for fiscal 2025.
View full Nuvectis Pharma company overviewNuvectis Pharma annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $31.7M | $13.1M | +70.41% |
| 2024 | 2024-12-31 | $18.6M | −$578,000 | −3.01% |
| 2023 | 2023-12-31 | $19.2M | −$1.2M | −5.98% |
| 2022 | 2022-12-31 | $20.4M | $13.7M | +206.52% |
| 2021 | 2021-12-31 | $6.7M | — | — |
Nuvectis Pharma quarterly total assets
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $22.4M | −$4.6M | −17.15% |
| Q1 2026 | 2026-03-31 | $25.4M | −$4.8M | −15.76% |
| Q4 2025 | 2025-12-31 | $31.7M | $13.1M | +70.41% |
| Q3 2025 | 2025-09-30 | $35.6M | $18.3M | +105.62% |
| Q2 2025 | 2025-06-30 | $27.0M | $8.7M | +47.60% |
| Q1 2025 | 2025-03-31 | $30.1M | $10.4M | +52.93% |
| Q4 2024 | 2024-12-31 | $18.6M | −$578,000 | −3.01% |
| Q3 2024 | 2024-09-30 | $17.3M | −$5.0M | −22.26% |
| Q2 2024 | 2024-06-30 | $18.3M | −$6.6M | −26.63% |
| Q1 2024 | 2024-03-31 | $19.7M | $3.5M | +21.63% |
| Q4 2023 | 2023-12-31 | $19.2M | −$1.2M | −5.98% |
| Q3 2023 | 2023-09-30 | $22.3M | −$2.6M | −10.47% |
| Q2 2023 | 2023-06-30 | $24.9M | $10.7M | +75.17% |
| Q1 2023 | 2023-03-31 | $16.2M | −$1.4M | −8.00% |
| Q4 2022 | 2022-12-31 | $20.4M | $13.7M | +206.52% |
| Q3 2022 | 2022-09-30 | $24.9M | — | — |
| Q2 2022 | 2022-06-30 | $14.2M | — | — |
| Q1 2022 | 2022-03-31 | $17.6M | — | — |
| Q4 2021 | 2021-12-31 | $6.7M | — | — |
Nuvectis Pharma total assets trends
Between the periods ended 2021-12-31 and 2025-12-31, Nuvectis Pharma's total assets increased from $6.7M to $31.7M, a change of $25.1M. The latest reported quarter, Q2 2026, shows $22.4M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Nuvectis Pharma source filings ↗